CD99 (E2) up-regulates alpha4beta1-dependent T cell adhesion to inflamed vascular endothelium under flow conditions.
about
CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesisAssociation of CD99 short and long forms with MHC class I, MHC class II and tetraspanin CD81 and recruitment into immunological synapses.The CD99 signal enhances Fas-mediated apoptosis in the human leukemic cell line, Jurkat.CD99 acts as an oncosuppressor in osteosarcomaGingipains of Porphyromonas gingivalis modulate leukocyte adhesion molecule expression induced in human endothelial cells by ligation of CD99.Induction of pathogenic sets of genes in macrophages and neurons in NeuroAIDS.Engagement of CD99 Reduces AP-1 Activity by Inducing BATF in the Human Multiple Myeloma Cell Line RPMI8226.Interaction of CD99 with its paralog CD99L2 positively regulates CD99L2 trafficking to cell surfacesCD99 polymorphisms significantly influence the probability to develop Ewing sarcoma in earlier age and patient disease progression.Similarities and differences in the regulation of leukocyte extravasation and vascular permeability.Human myeloma cell lines induce osteoblast downregulation of CD99 which is involved in osteoblast formation and activity.MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor.CD99 is upregulated in placenta and astrocytomas with a differential subcellular distribution according to the malignancy stage.CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activity.CD99 at the crossroads of physiology and pathology.Role of the adhesion molecule CD99 in platelet-neutrophil interactions.CD99 refers to the activity of inflammatory bowel disease.CD99: A Cell Surface Protein with an Oncojanus Role in Tumors.Large-Scale Arrayed Analysis of Protein Degradation Reveals Cellular Targets for HIV-1 Vpu.
P2860
Q24642797-918036E2-DDEE-4B4F-BF8D-D0BA68D7EAACQ33992087-02A9E1EB-D657-4E38-A33F-14AC604872C2Q34277320-5D2CA8F5-2392-4214-ABF7-B35665BF843AQ34483649-6EA2B5F5-9D1C-4F01-A0A5-FEE2640550C8Q34491722-FBC3740E-ACEC-4B38-8740-627D8F8A4FD3Q35791409-D92C7B2A-A996-4AA6-84A7-AE853C5A8123Q36260718-C4E10D4E-1A0E-44AE-8E9B-E1335BBA8A1AQ37317147-E24F64DC-37CE-4D9F-8FCA-5B2AC00AB94BQ37718471-5B54D252-5DA3-45D5-ADD9-89293EF315F7Q38196725-4C210B92-976D-4554-8E62-0315ACD37E91Q38298890-D267E47B-F143-4E25-89E6-9B188B56BB0AQ38321646-E0988993-F7E3-454E-B614-83D2591059E5Q38998414-A7563CE4-4C70-453E-BD82-8C66CFA2EFFFQ39156193-F97821D9-43CE-4D0F-AE5C-84C07E05E4B5Q47203268-38FF5735-07F4-4DD6-A79E-C2AF81DA503FQ47929258-D9F24393-B958-4FED-B370-AEB6A5AAA95EQ51315227-A74D990D-40EF-4D1F-9851-442DB75C0B39Q52658031-CDCEF19F-E345-4D3E-A952-E49D7556C092Q55034527-2CECBCF7-3E42-42F6-9992-885390B97A60
P2860
CD99 (E2) up-regulates alpha4beta1-dependent T cell adhesion to inflamed vascular endothelium under flow conditions.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
CD99 (E2) up-regulates alpha4b ...... thelium under flow conditions.
@ast
CD99 (E2) up-regulates alpha4b ...... thelium under flow conditions.
@en
type
label
CD99 (E2) up-regulates alpha4b ...... thelium under flow conditions.
@ast
CD99 (E2) up-regulates alpha4b ...... thelium under flow conditions.
@en
prefLabel
CD99 (E2) up-regulates alpha4b ...... thelium under flow conditions.
@ast
CD99 (E2) up-regulates alpha4b ...... thelium under flow conditions.
@en
P2093
P2860
P1476
CD99 (E2) up-regulates alpha4b ...... thelium under flow conditions.
@en
P2093
J Widjenes
M Pourtein
M Ticchioni
V Raimondi
P2860
P304
P356
10.1002/1521-4141(200010)30:10<3061::AID-IMMU3061>3.0.CO;2-M
P407
P577
2000-10-01T00:00:00Z